Skip to content

Maravai LifeSciences Holdings, Inc. MRVI Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Repligen logo
RepligenRGEN
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Maravai LifeSciences Holdings, Inc. (MRVI) reported deferred tax assets and other non-current assets of $40.24M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets decreased by 30.1% year-over-year, from $57.58M to $40.24M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s deferred tax assets and other non-current assets has grown at a 58.7% compound annual growth rate (CAGR), from $4.16M to $41.88M.